Keywords: fda, heads-up, new, rx, ad, guidelines, part

US FDA "heads-up" on new Rx ad guidelines

Article | 14 March 2005

Print This

As part of concerted moves by the US Food and Drug Administration to take a tougher stance on direct-to-consumer drug ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in